Dutch Promising Care subsidy scheme applications accepted since July 27, 2021

12

Jul 2021

The Promising Care subsidy scheme aims to speed up the patient's access to potentially promising care through temporary inclusion in the basic insurance package. A maximum of €69 million is available annually.

The first step for applying for a grant within the Promising Care subsidy scheme is submitting a project idea that substantiates the purpose and relevance of the research project. If the project idea is accepted, the independent advisory Committee invites these applicants to submit grant applications for the accepted project ideas.

The period for submitting a project idea within round 6 (the second round of projects to be awarded in 2022) of the subsidy scheme for promising care will start on July 27, 2021, and will last until September 28, 2021. Accepted project ideas will be announced not later than January 24, 2022. Applicants whose project ideas are accepted can submit a grant application until March 24, 2022.

On July 27, 2021, the Dutch Healthcare Institute (ZIN) will start accepting project idea applications for round 6 of the Promising Care subsidy. The application form for project idea submission and explanation for application (how to fill in the registration form at the ProjectNet website) are available for applicants.

The full details in Dutch can be found here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).

The latest related news

25

Mar 2022

On March 4, 2022, the Dutch Healthcare Institute (Zorginstituut Nederland, ZIN) announced three projects which received a subsidy under the "Subsidy scheme for promising care" in 2022 for research of a new minimally invasive endoscopy-guided surgery in patients with spontaneous cerebral hemorrhage, oral immunotherapy in children to cure a food allergy and cutting the diaphragm band in chronic abdominal complaints.

Read more

23

Mar 2022

In late January 2022, Swedish Medical Technologies Product (MTP) Council issued an updated version of recommendations regarding gene expression analysis for decision-making on the adjuvant breast cancer treatment, initially published in November 2021. The recommendation to the regions remains the same. The changes were only concerned with the clarification of some facts.

Read more

21

Mar 2022

The NHS Insights Prioritisation Programme (NIPP) is commissioned by the NHS Accelerated Access Collaborative (AAC) and the National Institute for Health Research (NIHR). It is designed to accelerate the evaluation and implementation of innovation that supports post-pandemic ways of working, builds service resilience, and delivers benefits to patients. Fourteen projects have been funded and have now commenced activity that will be ongoing until March 2023.

Read more

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

16

Mar 2022

In February 2022, Swedish Medical Technologies Product (MTP) Council issued an updated recommendation on FreeStyle Libre for continuous glucose monitoring in type 2 diabetes (T2D). The initial recommendations were published by NT Council in 2018 and updated by MTP Council in 2020 to include FreeStyle Libre 2. In the 2022 update, MTP Council decreased the Hba1c limit from 70 to 60 mmol/mol and added a statement on lifestyle changes and treatment optimization with non-insulin antidiabetic drugs.

Read more